Clinical Trials on Peripheral Primitive Fibromatosis in Australia
Total 357 results
-
Children's Oncology GroupNational Cancer Institute (NCI)CompletedNeuroblastomaUnited States, Australia
-
Children's Oncology GroupNational Cancer Institute (NCI)CompletedRecurrent Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor | Metastatic Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor | Localized Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor | Askin TumorUnited States, Canada, Puerto Rico, Australia, New Zealand, Switzerland
-
St. Anna KinderkrebsforschungUnknown
-
University Medicine GreifswaldChildren's Cancer Research Institute, AustriaActive, not recruiting
-
PfizerTerminatedNeuroblastomaAustralia, Korea, Republic of, United States, Portugal, New Zealand, Sweden
-
St. Anna KinderkrebsforschungCharite University, Berlin, Germany; Istituto Giannina Gaslini; St. Anna Children...Completed
-
Children's Oncology GroupNational Cancer Institute (NCI)Active, not recruitingLocalized Extraskeletal Ewing Sarcoma | Peripheral Primitive Neuroectodermal Tumor of Bone | Peripheral Primitive Neuroectodermal Tumor of Soft TissuesUnited States, Canada, Saudi Arabia, Australia, New Zealand, Puerto Rico
-
Eli Lilly and CompanyNew Approaches to Neuroblastoma Therapy Consortium (NANT); Innovative Therapies...Active, not recruitingNeuroblastomaUnited States, Spain, Australia, Belgium, Japan, France, Germany, Italy, United Kingdom
-
Novartis PharmaceuticalsInnovative Therapies For Children with Cancer ConsortiumRecruitingNeuroblastomaGermany, Italy, Singapore, Spain, United States, Australia, France
-
Children's Oncology GroupNational Cancer Institute (NCI); SpringWorks Therapeutics, Inc.Active, not recruitingDesmoid Fibromatosis | Recurrent Desmoid Fibromatosis | Unresectable Desmoid FibromatosisUnited States, Canada, Puerto Rico, Australia, New Zealand
-
Children's Oncology GroupNational Cancer Institute (NCI)Completed
-
University Children's Hospital TuebingenCompletedNeuroblastoma RecurrentGermany, Austria
-
Novartis PharmaceuticalsTerminatedNeuroblastoma | Malignant Rhabdoid Tumors (MRT)France, Germany, United Kingdom, United States, Australia
-
New Approaches to Neuroblastoma Therapy ConsortiumNational Cancer Institute (NCI)Active, not recruitingNeuroblastomaCanada, United States, Australia
-
St. Anna KinderkrebsforschungCentre Leon Berard; Medical University of Graz; Fondazione IRCCS Istituto Nazionale... and other collaboratorsUnknownNeuroblastomaFrance, Spain, Austria, Germany, Israel, Italy, United Kingdom
-
Medical University of GrazRecruitingMicrobial Colonization | Neuroblastoma | Children, OnlyAustria
-
University of BirminghamRoche Pharma AG; Cancer Research UK; Imagine for Margo; EUSA Pharma, Inc.Active, not recruitingNeuroblastomaFrance, Austria, Belgium, Denmark, Ireland, Italy, Spain, Switzerland, United Kingdom, Netherlands
-
European Infant Neuroblastoma Study Group - 1999CompletedCombination Chemotherapy Followed by Surgery in Treating Infants With Newly Diagnosed Neuroblastoma.NeuroblastomaSwitzerland, Denmark, Spain, Belgium, France, Austria, Italy, Norway, Portugal, Sweden, United Kingdom
-
European Infant Neuroblastoma Study Group - 1999CompletedNeuroblastomaSwitzerland, Denmark, Spain, United Kingdom, Belgium, France, Austria, Italy, Norway, Portugal, Sweden
-
European Infant Neuroblastoma Study Group - 1999CompletedNeuroblastomaSwitzerland, Denmark, Spain, Belgium, France, Austria, Italy, Norway, Portugal, Sweden, United Kingdom
-
European Infant Neuroblastoma Study Group - 1999CompletedNeuroblastomaSwitzerland, Denmark, Spain, Belgium, France, Austria, Italy, Norway, Portugal, Sweden, United Kingdom
-
Societe Internationale d'Oncologie PediatriqueChildren's Cancer and Leukaemia GroupCompletedNeuroblastomaSwitzerland, Spain, Germany, Belgium, France, Denmark, Austria, Italy, Norway, Portugal, Sweden, United Kingdom
-
Gustave Roussy, Cancer Campus, Grand ParisNational Cancer Institute, FranceTerminatedVery High Risk NeuroblastomaItaly, Austria, France, Netherlands, Spain
-
National Cancer Institute (NCI)Active, not recruitingGanglioneuroblastoma | High Risk NeuroblastomaUnited States, New Zealand, Australia
-
National Cancer Institute (NCI)CompletedUnspecified Childhood Solid Tumor, Protocol Specific | NeuroblastomaUnited States, Australia
-
EusaPharma (UK) LimitedUnited BioSource, LLCRecruitingNeuroblastomaFrance, Germany, United Kingdom, Italy, Austria, Poland, Spain
-
National Cancer Institute (NCI)CompletedPineoblastoma | Recurrent Medulloblastoma | Refractory Medulloblastoma | Refractory Peripheral Primitive Neuroectodermal Tumor | Central Nervous System Neoplasm | Recurrent Primitive Neuroectodermal TumorUnited States, Canada, Puerto Rico, Australia, New Zealand
-
University of LeicesterUnknownNeuroblastomaIreland, United Kingdom, France, Switzerland, Austria, Italy, Spain, Norway, Belgium, Denmark, Israel, Portugal, Sweden
-
St. Anna KinderkrebsforschungRecruitingNeuroblastomaNorway, Czechia, United Kingdom, France, Spain, Belgium, Switzerland, Hungary, Israel, Australia, Italy, Austria, Denmark, Greece, Ireland, Poland, Portugal, Slovakia, Slovenia, Sweden
-
Children's Oncology GroupNational Cancer Institute (NCI)CompletedNeuroblastomaUnited States, Canada, Australia, Puerto Rico, New Zealand, Netherlands
-
Children's Oncology GroupNational Cancer Institute (NCI)CompletedNeuroblastomaUnited States, Canada, Australia, Switzerland, Puerto Rico, Netherlands, New Zealand
-
Children's Oncology GroupNational Cancer Institute (NCI)Active, not recruitingNeuroblastoma | Ganglioneuroblastoma, NodularUnited States, Australia, Canada, New Zealand
-
Children's Oncology GroupNational Cancer Institute (NCI)CompletedNeuroblastomaUnited States, Canada, Puerto Rico, Australia, Netherlands, Switzerland, New Zealand
-
Alucent BiomedicalActive, not recruitingPAD - Peripheral Arterial DiseaseAustralia
-
Societe Internationale d'Oncologie PediatriqueUnknownNeuroblastomaIreland, United Kingdom, Spain, France, Italy, Netherlands, Switzerland, Austria
-
Instituto de Investigacion Sanitaria La FeCompletedLOW AND INTERMEDIATE PAEDIATRIC NEUROBLASTOMA AND NEONATAL SUPRARENAL MASSESSpain, Italy, Belgium, Denmark, Sweden, Norway, Israel, Switzerland, Australia, Austria
-
Biotronik CRC Inc.Biotronik AGActive, not recruiting
-
Children's Oncology GroupNational Cancer Institute (NCI)CompletedNeuroblastomaUnited States, Canada, Australia
-
Alucent BiomedicalActive, not recruitingPAD - Peripheral Arterial DiseaseAustralia
-
Gustave Roussy, Cancer Campus, Grand ParisRecruitingHigh-Risk NeuroblastomaFrance, Spain, United Kingdom, Norway, Sweden, Finland, Australia, Czechia, Italy, Netherlands, Slovenia, Switzerland, Belgium, Denmark, Greece, Lithuania
-
Eli Lilly and CompanyRecruitingRelapsed Solid Tumor | Refractory Solid TumorUnited States, Canada, Australia, Belgium, France, Spain, Germany, Italy
-
Sonnet BioTherapeuticsTerminatedChemotherapy-induced Peripheral Neuropathy (CIPN)Australia
-
Children's Oncology GroupNational Cancer Institute (NCI)Active, not recruitingNeuroblastoma | Localized Resectable Neuroblastoma | Localized Unresectable Neuroblastoma | GanglioneuroblastomaUnited States, Canada, Saudi Arabia, Puerto Rico, Australia, New Zealand
-
Children's Oncology GroupNational Cancer Institute (NCI)Active, not recruitingRecurrent Neuroblastoma | Refractory Neuroblastoma | High Risk NeuroblastomaUnited States, Canada, Puerto Rico, Australia, New Zealand
-
National Cancer Institute (NCI)United TherapeuticsCompletedRecurrent Neuroblastoma | GanglioneuroblastomaUnited States, Canada, Australia, New Zealand, Puerto Rico
-
Children's Oncology GroupNational Cancer Institute (NCI)CompletedNeuroblastoma | Brain Tumors | Central Nervous System TumorsUnited States, Australia, Canada
-
SIMR (Australia) Biotech Pty Ltd.CompletedPeripheral Neuropathic PainAustralia
-
Novartis PharmaceuticalsCompletedGlioma | Astrocytoma | Medulloblastoma | Neuroblastoma | Rhabdomyosarcoma | HepatoblastomaFrance, Canada, Italy, Australia, United Kingdom, United States
-
Biotronik CRC Inc.Not yet recruiting
-
Flinders UniversityThe Queen Elizabeth Hospital; Flinders Medical Centre; Royal Adelaide HospitalCompletedPeripheral Arterial DiseaseAustralia